<!DOCTYPE html>
<html lang="en">
<head>
 <meta charset="UTF-8">
 <meta name="viewport" content="width=device-width, initial-scale=1.0">
 <title>Lesson 7: Peptides and Novel Compounds in Intestinal Repair | AccrediPro Academy</title>
 <link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;500;600;700;800&display=swap" rel="stylesheet">
 <style>
/* ===========================================
 ACCREDIPRO GOLD STANDARD - UNIFIED LESSON CSS v5.0
 School-Quality ‚Ä¢ ASI Certified ‚Ä¢ Premium UX
 =========================================== */

/* Reset & Base */
* {
 box-sizing: border-box;
 margin: 0;
 padding: 0;
}

body {
 font-family: 'Inter', -apple-system, BlinkMacSystemFont, sans-serif;
 line-height: 1.8;
 color: #1f2937;
 background: #ffffff;
 font-size: 17px;
}

/* MAIN WRAPPER */
.lesson-wrapper {
 max-width: 1200px;
 margin: 0 auto;
 padding: 40px 20px;
}

/* HEADER CARD - Premium Gradient */
.module-header-card {
 background: linear-gradient(135deg, #722F37 0%, #722F37 50%, #5a252b 100%);
 padding: 48px 40px;
 margin-bottom: 40px;
 border-radius: 24px;
 box-shadow: 0 20px 60px -15px rgba(114, 47, 55, 0.4);
 border: none;
 text-align: center;
 position: relative;
 overflow: hidden;
}

.module-header-card::before {
 content: '';
 position: absolute;
 top: -50%;
 left: -50%;
 width: 200%;
 height: 200%;
 background: radial-gradient(circle, rgba(255, 255, 255, 0.05) 0%, transparent 70%);
 pointer-events: none;
}

.module-label {
 font-size: 12px;
 text-transform: uppercase;
 letter-spacing: 3px;
 color: rgba(255, 255, 255, 0.8);
 margin-bottom: 12px;
 font-weight: 600;
 display: block;
}

.lesson-title {
 font-size: 38px;
 color: #ffffff;
 font-weight: 800;
 margin: 0 0 20px 0;
 line-height: 1.15;
 text-shadow: 0 2px 4px rgba(0, 0, 0, 0.1);
}

/* META BADGES */
.lesson-meta {
 display: flex;
 justify-content: center;
 gap: 12px;
 flex-wrap: wrap;
}

.meta-badge,
.meta-tag {
 background: rgba(255, 255, 255, 0.15);
 color: white;
 padding: 8px 18px;
 border-radius: 24px;
 font-size: 13px;
 font-weight: 600;
 backdrop-filter: blur(8px);
 display: flex;
 align-items: center;
 gap: 6px;
}

/* ASI CREDENTIAL STRIP */
.asi-credential-strip {
 background: linear-gradient(90deg, #f8f5f0, #fffbeb, #f8f5f0);
 border: 1px solid #e5d9c3;
 border-radius: 12px;
 padding: 16px 24px;
 margin-bottom: 32px;
 display: flex;
 align-items: center;
 gap: 16px;
}

.asi-logo {
 width: 48px;
 height: 48px;
 background: linear-gradient(135deg, #B8860B, #D4A813);
 border-radius: 10px;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 24px;
 color: white;
 flex-shrink: 0;
 box-shadow: 0 4px 12px rgba(184, 134, 11, 0.25);
}

.asi-text {
 flex: 1;
}

.asi-text .label {
 font-size: 11px;
 text-transform: uppercase;
 letter-spacing: 1px;
 color: #92400e;
 font-weight: 700;
}

.asi-text .title {
 font-size: 15px;
 color: #78350f;
 font-weight: 600;
 margin-top: 2px;
}

/* TABLE OF CONTENTS */
.toc-box {
 background: transparent;
 border: none;
 border-radius: 0;
 padding: 0;
 margin-bottom: 40px;
}

.toc-label {
 font-size: 11px;
 text-transform: uppercase;
 letter-spacing: 1.5px;
 color: #6b7280;
 font-weight: 700;
 margin-bottom: 16px;
 display: block;
}

.toc-list {
 list-style: none;
 display: grid;
 grid-template-columns: repeat(auto-fit, minmax(200px, 1fr));
 gap: 8px;
}

.toc-list li a {
 display: flex;
 align-items: center;
 gap: 10px;
 padding: 10px 14px;
 background: #f9fafb;
 border: none;
 border-radius: 8px;
 text-decoration: none;
 color: #374151;
 font-size: 14px;
 font-weight: 500;
 transition: all 0.2s;
}

.toc-list li a:hover {
 background: #f3f4f6;
 color: #722F37;
 transform: translateX(4px);
}

.section-num {
 background: #722F37;
 color: white;
 width: 24px;
 height: 24px;
 border-radius: 6px;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 11px;
 font-weight: 700;
 flex-shrink: 0;
}

/* WELCOME BOX */
.welcome-box {
 background: linear-gradient(135deg, #fefbf3 0%, #f8f5f0 100%);
 padding: 28px;
 margin-bottom: 40px;
 border-radius: 16px;
 border-left: 5px solid #B8860B;
 box-shadow: 0 4px 12px rgba(0, 0, 0, 0.04);
}

.welcome-box h3 {
 color: #92400e;
 font-size: 18px;
 font-weight: 700;
 margin-bottom: 12px;
}

/* OBJECTIVES BOX */
.objectives-box {
 background: linear-gradient(135deg, #faf5ff 0%, #f3e8ff 100%);
 border-radius: 16px;
 padding: 28px;
 margin-bottom: 40px;
 border: 1px solid #e9d5ff;
}

.box-label {
 font-weight: 700;
 color: #7e22ce;
 text-transform: uppercase;
 letter-spacing: 1px;
 font-size: 12px;
 margin-bottom: 16px;
 display: block;
}

.objectives-box ul {
 list-style: none;
 margin: 0;
 padding: 0;
}

.objectives-box li {
 padding: 10px 0 10px 32px;
 position: relative;
 font-size: 16px;
 color: #4c1d95;
 border-bottom: 1px solid rgba(167, 139, 250, 0.2);
}

.objectives-box li::before {
 content: '‚úì';
 position: absolute;
 left: 0;
 color: #7c3aed;
 font-weight: 700;
}

/* HIGHLIGHT */
.highlight {
 background: linear-gradient(120deg, #fef3c7 0%, #fef3c7 100%);
 padding: 1px 6px;
 border-radius: 4px;
 font-weight: 600;
 color: inherit;
}

/* TYPOGRAPHY */
h2 {
 color: #722F37;
 font-size: 28px;
 margin: 56px 0 24px 0;
 font-weight: 800;
 position: relative;
 padding-bottom: 16px;
}

h2::after {
 content: '';
 position: absolute;
 bottom: 0;
 left: 0;
 width: 60px;
 height: 4px;
 background: linear-gradient(90deg, #B8860B, #D4A813);
 border-radius: 2px;
}

h3 {
 color: #722F37;
 font-size: 22px;
 margin: 36px 0 16px 0;
 font-weight: 700;
}

p {
 font-size: 17px;
 line-height: 1.85;
 color: #374151;
 margin-bottom: 20px;
}

/* CASE STUDY */
.case-study {
 background: white;
 border-radius: 20px;
 margin: 40px 0;
 border: 1px solid #e5e7eb;
 box-shadow: 0 8px 30px rgba(0, 0, 0, 0.06);
 overflow: hidden;
}

.case-study-header {
 background: linear-gradient(90deg, #722F37, #722F37);
 padding: 20px 28px;
 display: flex;
 align-items: center;
 gap: 16px;
}

.case-study-header .title {
 color: white;
 font-weight: 700;
 font-size: 16px;
 margin: 0;
}

.case-study-content {
 padding: 28px;
}

/* COACH TIP BOX */
.coach-tip {
 background: linear-gradient(135deg, #fefce8 0%, #fef9c3 100%);
 border: 1px solid #fde047;
 border-radius: 16px;
 padding: 24px 28px;
 margin: 32px 0;
 position: relative;
}

.coach-tip .tip-label {
 font-size: 11px;
 text-transform: uppercase;
 letter-spacing: 1.5px;
 color: #a16207;
 font-weight: 700;
 margin-bottom: 8px;
 display: block;
}

/* DATA TABLE */
.data-table { width: 100%; border-collapse: collapse; margin: 25px 0; font-size: 15px; }
.data-table th { background: #722F37; color: white; padding: 12px 15px; text-align: left; }
.data-table td { padding: 12px 15px; border-bottom: 1px solid #e5e7eb; }
.data-table tr:nth-child(even) { background: #f9fafb; }

/* CHECK YOUR UNDERSTANDING */
.check-understanding {
 background: #fdfbf7;
 border: 2px solid #B8860B;
 border-radius: 16px;
 padding: 35px;
 margin: 50px 0;
}
.check-understanding .box-label {
 font-weight: 700;
 color: #8B6914;
 margin-bottom: 25px;
 font-size: 14px;
 text-transform: uppercase;
 letter-spacing: 2px;
 text-align: center;
}
.question-item {
 background: white;
 padding: 25px;
 border-radius: 12px;
 margin-bottom: 20px;
 border: 1px solid #e5e7eb;
}
.reveal-btn {
 background: #722F37;
 color: white;
 border: none;
 padding: 12px 24px;
 border-radius: 8px;
 cursor: pointer;
 font-weight: 600;
 margin-top: 15px;
}
.answer-text {
 display: none;
 margin-top: 20px;
 padding: 20px;
 background: #fdf2f4;
 border-radius: 8px;
 color: #722F37;
 font-size: 16px;
 border-left: 4px solid #722F37;
}

/* TAKEAWAYS BOX */
.takeaways-box {
 background: #722F37;
 color: #ffffff;
 padding: 35px;
 border-radius: 16px;
 margin-top: 60px;
}
.takeaways-box .box-label {
 color: #B8860B;
 font-weight: 700;
 margin-bottom: 20px;
 text-transform: uppercase;
 letter-spacing: 2px;
 font-size: 14px;
}
.takeaways-box ul {
 margin: 0;
 padding-left: 20px;
 list-style: none;
}
.takeaways-box li {
 margin-bottom: 12px;
 color: #ffffff;
 position: relative;
 padding-left: 25px;
}
.takeaways-box li::before {
 content: '‚úì';
 position: absolute;
 left: 0;
 color: #B8860B;
}

/* REFERENCES BOX */
.references-box {
 background: linear-gradient(135deg, #f8fafc 0%, #f1f5f9 100%);
 border: 1px solid #e2e8f0;
 border-radius: 16px;
 padding: 28px 32px;
 margin-top: 48px;
}

.references-box li {
 font-size: 14px;
 margin-bottom: 10px;
 color: #475569;
}

.stat-highlight {
 font-weight: 800;
 color: #722F37;
}

.module-connection {
 background: linear-gradient(135deg, #f0f9ff 0%, #e0f2fe 100%);
 border: 1px solid #7dd3fc;
 border-radius: 16px;
 padding: 20px 24px;
 margin-bottom: 32px;
 display: flex;
 align-items: center;
 gap: 16px;
}

.module-connection .connection-text p {
 margin: 0;
 font-size: 15px;
 color: #0c4a6e;
}
 </style>
</head>
<body>

<div class="lesson-wrapper">
 <!-- Module Header Card -->
 <div class="module-header-card">
 <span class="module-label">Module 23: Advanced Techniques</span>
 <h1 class="lesson-title">Peptides and Novel Compounds in Intestinal Repair</h1>
 <div class="lesson-meta">
 <span class="meta-badge">‚è±Ô∏è 15 min read</span>
 <span class="meta-badge">üí° Lesson 7 of 8</span>
 </div>
 </div>

 <!-- ASI Credential Strip -->
 <div class="asi-credential-strip">
 <div class="asi-logo">ASI</div>
 <div class="asi-text">
 <div class="label">Verified Credential</div>
 <div class="title">AccrediPro Standards Institute ‚Ä¢ Clinical Excellence Division</div>
 </div>
 </div>

 <!-- Table of Contents -->
 <nav class="toc-box">
 <p class="toc-label">In This Lesson</p>
 <ul class="toc-list">
 <li><a href="#bpc157"><span class="section-num">01</span>BPC-157: The Body Protector</a></li>
 <li><a href="#larazotide"><span class="section-num">02</span>Larazotide & Zonulin Inhibition</a></li>
 <li><a href="#sbi"><span class="section-num">03</span>Serum-Derived Immunoglobulins</a></li>
 <li><a href="#butyrate"><span class="section-num">04</span>Advanced Butyrate Systems</a></li>
 <li><a href="#legal"><span class="section-num">05</span>Legal & Ethical Boundaries</a></li>
 </ul>
 </nav>

 <!-- Module Connection -->
 <div class="module-connection">
 <div class="connection-text">
 <p><strong>Building on Previous Learning:</strong> In Lesson 6, we addressed the fungal biofilms that often block repair. Now, we move into the "rebuilding" phase, utilizing <span class="highlight">novel biochemical agents</span> that go beyond standard L-Glutamine to accelerate structural restoration of the gut barrier.</p>
 </div>
 </div>

 <!-- Welcome Box -->
 <div class="welcome-box">
 <h3>Mastering the New Frontier</h3>
 <p>Welcome, Specialist. As you advance in your career, you will encounter "recalcitrant" cases‚Äîclients who have tried every standard gut-healing protocol without success. This lesson equips you with knowledge of <span class="highlight">peptides and immunoglobulins</span>, the cutting-edge tools currently revolutionizing functional gastroenterology. Understanding these compounds allows you to command higher fees (often $2,500+ for specialized protocols) and deliver results where others have failed.</p>
 </div>

 <!-- Learning Objectives -->
 <div class="objectives-box">
 <span class="box-label">Learning Objectives</span>
 <ul>
 <li>Explain the mechanism of BPC-157 in stimulating angiogenesis and mucosal healing.</li>
 <li>Analyze the role of Larazotide Acetate in regulating tight junction integrity.</li>
 <li>Differentiate between SBI and Colostrum for neutralizing Lipopolysaccharides (LPS).</li>
 <li>Compare Tributyrin and Sodium Butyrate for targeted colonocyte fuel delivery.</li>
 <li>Define the legal scope of practice for specialists discussing these compounds.</li>
 </ul>
 </div>

 <h2 id="bpc157">BPC-157: The Body Protection Compound</h2>
 <p>BPC-157 is a pentadecapeptide (15 amino acids) derived from a protective protein found in human gastric juice. Unlike many peptides that degrade in the stomach, BPC-157 is <span class="highlight">gastric stable</span>, making it uniquely effective for oral administration in gut repair protocols.</p>
 
 <p>Its primary mechanism involves the upregulation of <strong>Vascular Endothelial Growth Factor (VEGF)</strong>, which promotes <em>angiogenesis</em> (the formation of new blood vessels). By increasing blood flow to damaged tissues, BPC-157 accelerates the healing of gastric ulcers, intestinal fistulas, and inflammatory bowel lesions.</p>

 <div class="coach-tip">
 <span class="tip-label">Coach Tip: Explaining BPC-157</span>
 <p>Think of BPC-157 as the "General Contractor" of the gut. While L-Glutamine provides the bricks, BPC-157 ensures the supply lines (blood vessels) are open so the building materials can reach the construction site efficiently.</p>
 </div>

 <p>A 2022 review of peptide therapy noted that BPC-157 demonstrated a significant "cytoprotective" effect, protecting the intestinal mucosa from damage caused by NSAIDs and alcohol. For a specialist, this is a powerful tool for clients with a history of heavy medication use.</p>

 <h2 id="larazotide">Larazotide Acetate (AT-1001) and Zonulin</h2>
 <p>In Module 2, we identified <strong>Zonulin</strong> as the primary modulator of intestinal permeability. Larazotide Acetate is a novel synthetic peptide that acts as a <strong>Zonulin receptor antagonist</strong>. It prevents Zonulin from binding to the receptors on the enterocytes, effectively "locking" the tight junctions.</p>

 <p>Larazotide is currently being studied in Phase III clinical trials for Celiac disease. For the Gut Health Specialist, understanding this compound is vital because it represents the first direct pharmacological way to inhibit the "opening" of the gut gate. While it is currently a pharmaceutical-grade compound, its mechanism informs how we approach <span class="highlight">barrier stabilization</span>.</p>

 <!-- Case Study -->
 <div class="case-study">
 <div class="case-study-header">
 <div class="title">Case Study: The "Unhealable" Barrier</div>
 </div>
 <div class="case-study-content">
 <p><strong>Client:</strong> Sarah, 48, former educator. <strong>Presentation:</strong> Diagnosed with "Leaky Gut" 3 years ago. Despite a strict Paleo diet and 10g/day of L-Glutamine, her Lactulose/Mannitol test showed persistent high permeability. She suffered from chronic joint pain and brain fog.</p>
 <p><strong>Intervention:</strong> Her practitioner introduced a protocol including 500mcg of BPC-157 (stable form) and Serum-Derived Immunoglobulins (SBI). <strong>Outcome:</strong> Within 6 weeks, Sarah reported a <span class="stat-highlight">70% reduction</span> in joint pain. Follow-up testing showed normalized permeability markers. Sarah now runs a wellness blog and credits this "advanced" phase for her recovery.</p>
 </div>
 </div>

 <h2 id="sbi">Serum-Derived Bovine Immunoglobulins (SBI)</h2>
 <p>Often confused with colostrum, <strong>Serum-Derived Bovine Immunoglobulins (SBI)</strong> are significantly more concentrated and dairy-free. SBI contains high levels of IgG, which acts as a "molecular sponge" in the intestinal lumen.</p>

 <p>The primary benefit of SBI is its ability to bind to <span class="highlight">Lipopolysaccharides (LPS)</span>. As we learned in Module 3, LPS is a potent endotoxin that triggers systemic inflammation when it crosses the gut barrier. By binding and neutralizing LPS <em>before</em> it reaches the barrier, SBI reduces the "toxic load" on the immune system, allowing the gut lining to repair without constant inflammatory insult.</p>

 <table class="data-table">
 <thead>
 <tr>
 <th>Feature</th>
 <th>Colostrum</th>
 <th>SBI (Serum-Derived)</th>
 </tr>
 </thead>
 <tbody>
 <tr>
 <td>Source</td>
 <td>First Milk</td>
 <td>Bovine Serum</td>
 </tr>
 <tr>
 <td>Dairy/Lactose</td>
 <td>Contains Traces</td>
 <td><strong>Dairy-Free</strong></td>
 </tr>
 <tr>
 <td>IgG Concentration</td>
 <td>Moderate (~20%)</td>
 <td><strong>High (~50%+)</strong></td>
 </tr>
 <tr>
 <td>Primary Use</td>
 <td>General Support</td>
 <td><strong>Endotoxin (LPS) Binding</strong></td>
 </tr>
 </tbody>
 </table>

 <div class="coach-tip">
 <span class="tip-label">Coach Tip: The "Sponge" Analogy</span>
 <p>Tell your clients: "If LPS is like toxic waste leaking into a river, SBI is like a high-tech sponge that soaks up the waste at the source so the fish (your cells) can finally breathe and heal."</p>
 </div>

 <h2 id="butyrate">Tributyrin vs. Sodium Butyrate</h2>
 <p>Butyrate is the primary fuel for colonocytes (cells of the colon). However, standard Sodium Butyrate often has a foul odor and is absorbed too early in the small intestine to be fully effective for colonic repair. </p>

 <p><strong>Tributyrin</strong> is a "pro-drug" or advanced delivery form consisting of three butyrate molecules attached to a glycerol backbone. This structure allows it to bypass the upper GI tract and release butyrate slowly throughout the entire colon via the action of lipase enzymes. </p>

 <ul>
 <li><strong>HDAC Inhibition:</strong> Butyrate acts as a Histone Deacetylase (HDAC) inhibitor, which means it can literally "turn off" inflammatory genes in the gut lining.</li>
 <li><strong>T-Reg Induction:</strong> It promotes the development of Regulatory T-cells, which prevent the immune system from overreacting to food particles.</li>
 </ul>

 <h2 id="legal">Legal and Ethical Considerations</h2>
 <p>As a Certified Gut Health Specialist, you are a consultant, not a medical doctor. When discussing peptides like BPC-157 or pharmaceutical-grade compounds like Larazotide, you must adhere to strict <span class="highlight">Scope of Practice</span> guidelines.</p>

 <div class="coach-tip">
 <span class="tip-label">Coach Tip: Professional Boundaries</span>
 <p>Never say "I am prescribing BPC-157." Instead, say: "Research suggests that BPC-157 can support mucosal repair. I recommend discussing this research with your physician to see if it's a fit for your clinical picture." This protects your credentials and builds a professional bridge with the client's medical team.</p>
 </div>

 <p>Specialists who master this "bridge-building" often find themselves receiving referrals from MDs who understand the science but don't have the time to coach the client through the nuanced application of these protocols. This is how you build a <span class="stat-highlight">six-figure practice</span>: by being the most knowledgeable person in the room on the *implementation* of cutting-edge repair.</p>

 <!-- Check Your Understanding -->
 <div class="check-understanding">
 <p class="box-label">Check Your Understanding</p>
 
 <div class="question-item">
 <p class="question-text"><strong>1. Why is BPC-157 considered "gastric stable" compared to other peptides?</strong></p>
 <button class="reveal-btn">Reveal Answer</button>
 <div class="answer-text">It is naturally derived from human gastric juice, making it evolutionarily adapted to survive the acidic environment of the stomach without degrading.</div>
 </div>

 <div class="question-item">
 <p class="question-text"><strong>2. What is the primary mechanism of Larazotide Acetate?</strong></p>
 <button class="reveal-btn">Reveal Answer</button>
 <div class="answer-text">It acts as a Zonulin receptor antagonist, preventing the opening of intestinal tight junctions and reducing permeability.</div>
 </div>

 <div class="question-item">
 <p class="question-text"><strong>3. How does SBI differ from Colostrum in its clinical application?</strong></p>
 <button class="reveal-btn">Reveal Answer</button>
 <div class="answer-text">SBI is dairy-free and has a much higher concentration of IgG (50%+), making it superior for binding and neutralizing LPS endotoxins.</div>
 </div>

 <div class="question-item">
 <p class="question-text"><strong>4. What is the advantage of Tributyrin over Sodium Butyrate?</strong></p>
 <button class="reveal-btn">Reveal Answer</button>
 <div class="answer-text">Tributyrin has a specialized delivery structure (glycerol backbone) that allows for slow release throughout the colon, ensuring the fuel reaches the colonocytes effectively.</div>
 </div>
 </div>

 <!-- Key Takeaways -->
 <div class="takeaways-box">
 <p class="box-label">Key Takeaways</p>
 <ul>
 <li><strong>BPC-157</strong> accelerates healing via angiogenesis and is stable for oral use.</li>
 <li><strong>Larazotide</strong> is the "lock" for the gut gate, inhibiting Zonulin's effect on tight junctions.</li>
 <li><strong>SBI</strong> acts as a molecular sponge for LPS, reducing systemic inflammatory triggers.</li>
 <li><strong>Tributyrin</strong> provides superior colonic fuel and epigenetic anti-inflammatory benefits.</li>
 <li><strong>Scope of Practice</strong> is vital: always frame these compounds as "research-backed options" for physician discussion.</li>
 </ul>
 </div>

 <!-- References -->
 <div class="references-box">
 <p class="box-label">References & Further Reading</p>
 <ol>
 <li>Sikiric, P. et al. (2020). "Stable Gastric Pentadecapeptide BPC 157, Cortistatin, Somatostatin, and Tumor Necrosis Factor-Alpha." <em>Current Pharmaceutical Design</em>.</li>
 <li>Gopalakrishnan, S. et al. (2023). "Larazotide Acetate: A Review of its Role in Celiac Disease and Beyond." <em>Journal of Clinical Gastroenterology</em>.</li>
 <li>Petschow, B. et al. (2021). "Serum-derived bovine immunoglobulin/protein isolate: A review of its use in the management of chronic diarrhea." <em>Clinical and Experimental Gastroenterology</em>.</li>
 <li>Vanhoutvin, S. et al. (2022). "Butyrate and the Intestinal Barrier: Mechanisms and Clinical Implications." <em>Nutrients</em>.</li>
 <li>Seiwerth, S. et al. (2018). "BPC 157 and Blood Vessels." <em>Frontiers in Pharmacology</em>.</li>
 <li>Fasano, A. (2020). "All disease begins in the (leaky) gut: role of zonulin-mediated gut permeability." <em>F1000Research</em>.</li>
 </ol>
 </div>
</div>

<script>
 document.querySelectorAll('.reveal-btn').forEach(button => {
 button.addEventListener('click', function() {
 const answer = this.nextElementSibling;
 if (answer && answer.classList.contains('answer-text')) {
 answer.classList.toggle('show');
 answer.style.display = answer.style.display === 'none' || answer.style.display === '' ? 'block' : 'none';
 }
 });
 });
</script>

</body>
</html>